Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Walking, gentle yoga, and low-intensity activities help maintain activity without overstressing a body that may already feel uncomfortable
Serious but rare risks include: Pancreatitis (inflammation of the pancreas): Contact your OBGYN immediately if you experience severe, persistent abdominal pain that may radiate to your back
Sources Novo Nordisk Wegovy HD (semaglutide 7.2 mg) FDA approval announcement, March 2026 The Lancet Diabetes & Endocrinology STEP UP trial: once-weekly semaglutide 7.2 mg in adults with obesity (2025) FDA Wegovy (semaglutide) prescribing information, 2025 PR Newswire FDA approves Wegovy HD injection (Novo Nordisk press release) NovoCare Wegovy cost and coverage information ClinicalTrials.gov STEP UP trial protocol (NCT05646706) New England Journal of Medicine STEP 1 trial: once-weekly semaglutide 2.4 mg Medical disclaimer This article is for informational purposes only and does not replace medical advice
This article is for informational purposes only and is not meant to offer medical advice
US$ 27.20
US$ 26.01
US$ 28.43
US$ 28.27
US$ 29.90
US$ 26.93
US$ 21.19
US$ 21.90
US$ 24.14
US$ 21.72
US$ 29.35
US$ 25.42
